Print

ANNOUNCEMENT TO ALL PHA CARDIOLOGISTS: DOH Medicine Access Program extends availment of FREE ALTEPLASE for use in patients with acute STEMI and pulmonary embolism

The Department of Health has extended the availment and use of recombinant tissue plasminogen activator rtPA Alteplase, a thrombolytic for use in patients with acute ST elevation myocardial infarction and pulmonary embolism. The drug will be made available for FREE for indigent patients subject to the regulations and documentation protocols set by the DOH. Please see the attached circulars.

PHA20100.PDF

DM2016-0443.PDF

DM2017-0068.PDF